Neurolase Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $40K

  • Investors
  • 3

Neurolase General Information

Description

Developer of neurosurgical technology designed to improve the safety and precision of brain tumour surgery. The company's platform incorporates advanced technology to support greater accuracy and risk reduction during surgical procedures, enabling neurosurgeons and healthcare providers with tools to perform brain tumour operations with increased control and reliability, supporting improved patient outcomes in neurosurgical care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15 Denholme Road
  • London W9 3HU
  • England, United Kingdom
Primary Industry
Surgical Devices
Corporate Office
  • 15 Denholme Road
  • London W9 3HU
  • England, United Kingdom

Neurolase Timeline

2026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurolase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jul-2026 $40K Completed Generating Revenue
2. Early Stage VC 01-Apr-2026 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Neurolase’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Neurolase Patents

Neurolase Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026093326-A1 Methods and apparatus for in vivo molecular characterisation Pending 29-Oct-2024

Neurolase Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurolase Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Francis Crick Institute Accelerator/Incubator
Oxford Technology Management Venture Capital Minority
Zinc Venture Capital Minority
To view Neurolase’s complete investors history, request access »

Neurolase FAQs

  • When was Neurolase founded?

    Neurolase was founded in 2025.

  • Where is Neurolase headquartered?

    Neurolase is headquartered in London, United Kingdom.

  • What is the size of Neurolase?

    Neurolase has 2 total employees.

  • What industry is Neurolase in?

    Neurolase’s primary industry is Surgical Devices.

  • Is Neurolase a private or public company?

    Neurolase is a Private company.

  • What is Neurolase’s current revenue?

    The current revenue for Neurolase is .

  • How much funding has Neurolase raised over time?

    Neurolase has raised $40K.

  • Who are Neurolase’s investors?

    The Francis Crick Institute, Oxford Technology Management, and Zinc have invested in Neurolase.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process